login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CLIMB BIO INC (CLYM) Stock News
USA
- NASDAQ:CLYM -
US28658R1068
-
Common Stock
1.95
USD
+0.05 (+2.63%)
Last: 11/17/2025, 10:31:01 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CLYM Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Climb Bio, Inc.
Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
11 days ago - By: Climb Bio, Inc.
Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
14 days ago - By: Climb Bio, Inc.
Climb Bio to Present at Upcoming Investor Conferences
14 days ago - By: Climb Bio, Inc.
Climb Bio to Present at Upcoming Investor Conferences
a month ago - By: Climb Bio, Inc.
Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy
a month ago - By: Climb Bio, Inc.
Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy
a month ago - By: Benzinga
- Mentions:
IBIO
ABP
AVR
STTK
...
12 Health Care Stocks Moving In Monday's After-Market Session
a month ago - By: Climb Bio, Inc.
Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025
a month ago - By: Climb Bio, Inc.
Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025
a month ago - By: Benzinga
- Mentions:
AMGN
BIIB
NVS
TGTX
Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity
2 months ago - By: Climb Bio, Inc.
Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer
2 months ago - By: Climb Bio, Inc.
Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer
2 months ago - By: Climb Bio, Inc.
Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN
2 months ago - By: Climb Bio, Inc.
Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN
2 months ago - By: Climb Bio, Inc.
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025
2 months ago - By: Climb Bio, Inc.
Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025
3 months ago - By: Zacks Investment Research
Climb Bio, Inc. (CLYM)'s Technical Outlook is Bright After Key Golden Cross
3 months ago - By: Climb Bio, Inc.
UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences
3 months ago - By: Climb Bio, Inc.
UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences
3 months ago - By: Climb Bio, Inc.
Climb Bio to Present at Upcoming September 2025 Investor Conferences
3 months ago - By: Zacks Investment Research
- Mentions:
COR
Is Climb Bio, Inc. (CLYM) Outperforming Other Medical Stocks This Year?
3 months ago - By: Climb Bio, Inc.
Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
3 months ago - By: Climb Bio, Inc.
Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
4 months ago - By: Yahoo Finance
- Mentions:
WVE
Oppenheimer Predicts Up to 590% Rally for These 2 ‘Strong Buy’ Stocks
5 months ago - By: Climb Bio, Inc.
Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer
5 months ago - By: Climb Bio, Inc.
Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer
6 months ago - By: Climb Bio, Inc.
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
6 months ago - By: Climb Bio, Inc.
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
6 months ago - By: Climb Bio, Inc.
Climb Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
7 months ago - By: Yahoo Finance
- Mentions:
FLD
REX
STKS
TSLA
Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX
8 months ago - By: Climb Bio, Inc.
- Mentions:
ABOS
LENZ
SLDB
VERV
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
8 months ago - By: Climb Bio, Inc.
Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference
8 months ago - By: Yahoo Finance
- Mentions:
C
OKTA
CORW
ABBV
...
Climb Bio Fueled Up with Cash, Poised for More Milestones in ’25 – Quarterly Update Report
Please enable JavaScript to continue using this application.